Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Feb 28, 2019, after the close
10-K filed Feb 28, 2019, 59 days after period end · 0001558370-19-001310
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $37.86M | $0.00 | — | — |
| Net Income | $3.23M | -$25.87M | -$15.59M | — |
| EPS Diluted |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| $0.02 |
| -$0.18 |
| -$0.16 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
